RAMSIS F. GHALY, MD

Plain English
This study looked at the use of a device called a percutaneous micro-axial flow pump (mAFP) during risky heart procedures known as percutaneous coronary interventions (PCI). Researchers found that using the mAFP did not lower the chances of serious heart problems or death within 30 days or a year compared to those who did not use it. However, patients who received the pump before the procedure had higher risks of major bleeding and heart attacks while in the hospital. Who this helps: This research helps doctors and healthcare professionals making decisions about heart procedures for high-risk patients.

Plain English
This study looked at how the advanced lung cancer inflammation index (ALI) affects survival rates in patients with heart failure. It found that patients with a low ALI (25 or lower) had a 73% higher risk of dying from any cause compared to those with a high ALI (above 25). In fact, having a high ALI was linked to a 56% lower risk of death overall. This is important because it means ALI could help doctors predict which heart failure patients are at a greater risk of dying and tailor their treatment accordingly. Who this helps: This helps patients with heart failure and their doctors.

Plain English
This study looked at how the right side of the heart's function, specifically using two measurements (TAPSE and TAPSE:PASP ratio), affects survival and health outcomes in patients receiving a Mitra-clip procedure, which helps treat severe mitral valve problems. The researchers found that patients with right ventricular dysfunction had significantly worse outcomes after the procedure, with survival rates dropping from 90.5% to 81.8% at six months for those with dysfunction and reduced heart failure readmission-free survival also declining. This is important because it helps doctors better assess risks and manage treatment plans for patients with heart failure undergoing Mitra-clip. Who this helps: This helps patients with heart failure and their doctors.

Plain English
This study looked at a treatment called transcatheter edge-to-edge repair (TEER) for patients suffering from severe mitral regurgitation who were not responding well to standard medications. It found that TEER led to a 27% reduction in hospitalizations for heart failure and a 21% decrease in cardiovascular deaths within two years. The treatment also improved patients' quality of life, with scores increasing by an average of 14 points on a key health questionnaire. Who this helps: This benefits patients with severe heart failure and mitral regurgitation.

Plain English
This study looked at how a type of diabetes medication called SGLT2 inhibitors affects the way the heart uses glucose. The researchers found that 64.7% of patients taking SGLT2 inhibitors had no measurable heart glucose use compared to 37.4% of those not on the medication. Additionally, the heart glucose uptake was significantly lower in those treated with SGLT2 inhibitors, despite having higher blood sugar levels before testing. This is important because it enhances our understanding of how these medications work on the heart, which could change how doctors perform certain heart imaging tests. Who this helps: This helps patients with diabetes and heart conditions, as well as the doctors who treat them.

Plain English
This study looks at how to treat severe anemia in a 42-year-old Jehovah's Witness woman who could not receive blood transfusions due to her beliefs. Instead of traditional treatments, doctors used a combination of intravenous iron, hormones to help make red blood cells, and specific vitamins, which helped manage her condition. The findings highlight the need for better guidelines on treating severe anemia in patients like her while respecting their beliefs. Who this helps: This benefits patients with severe anemia, especially those who refuse blood transfusions, as well as their doctors.

Plain English
This study looked at a newer method called high-power short-duration (HPSD) ablation for treating atrial fibrillation (AF) compared to the traditional standard-power long-duration (SPLD) ablation. Researchers found that HPSD ablation led to a total procedure time that was about 23 minutes shorter and a pulmonary vein isolation time that was almost 20 minutes shorter, without increasing risks for injuries or complications. This matters because quicker procedures can lead to better patient experiences and potentially lower healthcare costs. Who this helps: Patients with atrial fibrillation needing ablation treatment.

Plain English
This study looked at how effective a heart procedure called Mitra-Clip is for patients with severe mitral regurgitation (a leaky heart valve) who did not improve with another treatment called cardiac resynchronization therapy (CRT). The researchers found that after receiving the Mitra-Clip, 84% of these patients had a significant reduction in valve leakage within six months, and 71% reported improved symptoms. Over two years, about 26% of patients died, which is comparable to results seen in other studies with similar patients. Who this helps: This benefits heart failure patients with leaky valves who have not responded to standard therapies.

Plain English
This study looked at clinical decision support systems (CDSS) to see if they could help doctors follow guidelines for prescribing blood thinners to patients with atrial fibrillation, a heart condition. The researchers analyzed nine trials involving over 25,500 patients and found that using CDSS didn't significantly change the number of patients receiving these medications or the rates of serious complications like bleeding or death. However, using CDSS did reduce the risk of heart attacks by 82% and serious blood clots in the brain or body by 89%, making it a valuable tool for patient safety. Who this helps: Patients with atrial fibrillation.

Plain English
This study looked at the heart medication levosimendan to see how effective and safe it is for people with advanced heart failure. The researchers found that patients who took levosimendan had a better heart function, measured by the percentage of blood the heart pumps out with each beat, improving by about 6.4 percentage points compared to those who received a placebo. Additionally, those taking levosimendan had a 40% lower risk of dying from any cause. However, there was no difference in rates of hospital readmission. Who this helps: This benefits patients with advanced heart failure.

Plain English
This study looked at the use of lymphodepleting chemotherapy before T cell receptor-engineered T cell (TCR-T) therapy in patients with advanced solid tumors. It found that a common chemotherapy combination—Cyclophosphamide and Fludarabine—was used in 38% of the analyzed studies. While higher doses of this chemotherapy led to more occurrences of a serious side effect called febrile neutropenia (64% compared to 39% for lower doses), they didn't significantly improve treatment effectiveness. This is important because it highlights the need for better safety data and guidelines to help find the best chemotherapy dose for patients undergoing TCR-T therapy. Who this helps: Patients with advanced solid tumors receiving TCR-T therapy.

Plain English
This research studied the outcomes of 173 patients with plasmablastic lymphoma (PBL), an aggressive form of non-Hodgkin lymphoma. It found that 45% of patients responded completely to initial chemotherapy, with a two-year survival rate of about 47%. The results indicate that more intense chemotherapy improves survival, especially for patients with high-risk characteristics like advanced stage or specific viral infections. Who this helps: This information benefits patients with plasmablastic lymphoma and their doctors by guiding treatment decisions.

Plain English
This study looked at various factors to figure out why some countries had higher COVID-19 death rates than others. The researchers found that higher average body mass index (BMI) in a country was strongly linked to more deaths, with a serious correlation value of 0.43, while the country's economic strength (GDP) had the highest link at 0.65. Understanding these factors helps us identify communities at higher risk, which is important for planning healthcare responses. Who this helps: This helps health officials and policymakers in targeting resources for at-risk populations.

Plain English
This study looked at how to manage complex regional pain syndrome (CRPS) in a patient who had serious nerve damage from a car accident. The 43-year-old man experienced severe pain and weakness after losing function in a specific nerve due to the accident. After undergoing a series of stellate ganglion blocks, which are injections to relieve pain, his condition improved significantly—his pain and strength saw a 75% improvement. This is important because it shows that these injections can effectively help patients with CRPS following severe nerve injuries, even when surgery isn't an option. Who this helps: Patients suffering from chronic pain after nerve injuries.

Plain English
This study explored a new way to prevent the spread of the coronavirus during surgery by using a clear plastic barrier with suction. When this method was tested on a 49-year-old man needing spinal surgery, it successfully reduced the risk of viral transmission while the doctors worked. The patient reported a positive experience with the procedure, highlighting the method's effectiveness in keeping both patients and medical staff safer during surgeries. Who this helps: This helps patients and healthcare providers, especially during surgeries involving intubation.

Plain English
This study looked at a 34-year-old woman with chronic neck pain who had tried many treatments, including strong painkillers called opioids, without long-term relief. After suffering a life-threatening reaction to these medications, she had surgery to fix her cervical disc herniation, which led to significant pain improvement and allowed her to stop using opioids within six weeks. This is important because it shows that early surgery may prevent the complications and dependencies that can come from long-term opioid use. Who this helps: This helps patients with cervical disc problems and their doctors.

Plain English
This study looked at how far the skin is from the epidural space (the area where injections for pain relief are given) in the neck and upper back using MRI scans from 100 patients with chronic headaches and arm pain. They found that the distance from the skin to the epidural space averaged 5.7 cm at certain neck levels but decreased in lower areas, specifically down to 4.7 cm at the thoracic (upper back) levels. The researchers also discovered that a buildup of fat in the neck area, particularly in obese patients, can affect these distances and potentially influence the safety of epidural injections. Who this helps: This research benefits doctors performing pain management procedures, especially in patients who are obese.

Plain English
This study examined patients who developed a condition called postlaminectomy pseudomeningocele, which can cause chronic low back pain after spinal surgery. The researchers looked at six cases and found that all patients had a noticeable lump under their surgical scar, experienced sensory loss in their legs, and reported pain when tapping their heels. They noted that these patients had a history of smoking and multiple spinal surgeries, highlighting the importance of careful examination by pain specialists to avoid complications during treatment. Who this helps: This helps patients dealing with persistent back pain after spine surgery.

Plain English
This study looked at a patient who experienced ongoing pain after suffering an electrical burn. Initially, the pain showed up where the electricity entered the body, but surprisingly, it later developed at the exit point after almost a year. The researchers found that treatments like nerve blocks and physical therapy helped manage this pain effectively. Who this helps: This helps patients who suffer from pain after electrical burns.